Adjuvant therapy for renal-cell carcinoma: settled for now

被引：15
|
作者：
Duensing, Stefan [1 ,2 ]
Hohenfellner, Markus [2 ]
机构：
[1] Heidelberg Univ, Med Fac Heidelberg, Sect Mol Urooncol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Med Fac Heidelberg, Dept Urol, D-69120 Heidelberg, Germany
来源：
LANCET | 2016年 / 387卷 / 10032期
关键词：
IMATINIB MESYLATE; INTERFERON; SUNITINIB; ALPHA;
D O I：
10.1016/S0140-6736(16)00653-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1973 / 1974
页数：2
相关论文
共 50 条
  • [1] Adjuvant therapy in renal-cell carcinoma: Is it prime time yet?
    Dimitriadis, John
    Bamias, Aristotelis
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S360 - S362
  • [2] Adjuvant therapy in renal-cell carcinoma: New drugs, old problems
    Portugal, Gaspar F.
    Silva, A. B.
    Mota, R. L.
    Lopes, F. A.
    Monteiro, L. A.
    [J]. EUROPEAN UROLOGY, 2023, 83 : S670 - S670
  • [3] Adjuvant Sunitinib in Renal-Cell Carcinoma REPLY
    Ravaud, Alain
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09): : 893 - 893
  • [4] The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma
    Mckay, Rana R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 756 - 758
  • [5] INTERFERON THERAPY FOR RENAL-CELL CARCINOMA
    MUSS, HB
    [J]. SEMINARS IN ONCOLOGY, 1987, 14 (02) : 36 - 42
  • [6] CURRENT THERAPY FOR RENAL-CELL CARCINOMA
    MCDONALD, MW
    [J]. JOURNAL OF UROLOGY, 1982, 127 (02): : 211 - 217
  • [7] ROLE OF ADJUVANT RADIOTHERAPY IN MANAGEMENT OF RENAL-CELL CARCINOMA
    RAFLA, S
    PARIKH, KJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (10): : 1418 - 1418
  • [8] Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Symeonides, S. N.
    Hajek, J.
    Chang, Y-H
    Lee, J-L
    Sarwar, N.
    Haas, N. B.
    Gurney, H.
    Sawrycki, P.
    Mahave, M.
    Gross-Goupil, M.
    Zhang, T.
    Burke, J. M.
    Doshi, G.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Oudard, S.
    Topart, D.
    Hammers, H.
    Kitamura, H.
    McDermott, D. F.
    Silva, A.
    Winquist, E.
    Cornell, J.
    Elfiky, A.
    Burgents, J. E.
    Perini, R. F.
    Powles, T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (15): : 1359 - 1371
  • [9] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Chang, Y. -H.
    Hajek, J.
    Symeonides, S. N.
    Lee, J. L.
    Sarwar, N.
    Thiery-Vuillemin, A.
    Gross-Goupil, M.
    Mahave, M.
    Haas, N. B.
    Sawrycki, P.
    Gurney, H.
    Chevreau, C.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Burke, J. M.
    Doshi, G.
    Topart, D.
    Oudard, S.
    Hammers, H.
    Kitamura, H.
    Bedke, J.
    Perini, R. F.
    Zhang, P.
    Imai, K.
    Willemann-Rogerio, J.
    Quinn, D. I.
    Powles, T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 683 - 694
  • [10] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Sharma, Aparna
    Sahoo, Ranjit K.
    Batra, Atul
    Bleyer, Archie
    Choueiri, Toni K.
    Powles, Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20): : 1919 - 1920
12345